TEORICO 3 Aplasias Medulares 2022

Aplasia Medular Overview

This section provides an in-depth discussion on aplasia medular, focusing on its characteristics, historical context, causes, and implications within the field of hematology.

Characteristics of Aplasia Medular

• Aplasia medular involves the peripheral destruction of red blood cells, leading to a response from the bone marrow with erythroid hyperplasia.

• The loss in aplasia medular is primarily at a cellular level in the bone marrow, affecting cell maturation and expression in peripheral blood.

Historical Context and Causes

• Aplasia medular was first described by Ehrlich in 1888 as a syndrome characterized by peripheral pancytopenia linked to hypocellularity of the erythropoietic clone.

• The condition became more prevalent in the 20th century due to factors like cyclic chemicals (e.g., benzene), drugs (e.g., chloramphenicol), and antibiotics causing pandemias.

Understanding Aplasia Medular

• Aplasia medular pertains to quantitative disorders involving disappearance of hematopoietic precursors, replacement by fat cells (yellow marrow), and resulting pancytopenia.

• It is crucial to differentiate between pancytopenia and anemia; severe cases without treatment have short survival rates.

Impact of Aplasia Medular

This section delves into the impact of aplasia medular through notable historical cases like Marie Curie's experience and discusses how it affects patients' health outcomes.

Notable Cases

• Marie Curie's experience with aplasia medular due to radiation exposure highlights the severe consequences associated with this condition.

• Dr. Bernardini de Masnata's case underscores how researchers working with radioactive isotopes can also be susceptible to aplastic conditions.

Health Implications

• Patients with aplasia medular face challenges such as leukopenia, anemia, and thrombocytopenia which significantly impact their immune system function and overall health.

• Various factors can induce aplastic conditions; caution must be exercised with medications as they can potentially lead to aplastic reactions.

Epidemiological Insights

This segment explores epidemiological aspects related to aplasia medular incidence based on gender distribution, age groups affected, and regional disparities observed globally.

Gender Distribution & Age Factors

• Artemisinin's impact on blocking erythropoietin stimulation showcases how gender does not play a predominant role in predisposing individuals to aplastic conditions.

Regional Disparities

New Section

In this section, the speaker discusses optimal living conditions in the United States and how aplasia incidence is similar among Caucasians. The focus shifts to environmental and nutritional factors that may trigger medullary aplasia.

Optimal Living Conditions and Aplasia Incidence

• The incidence of aplasia is similar among Caucasians in the United States, suggesting it is not a racial issue.

• Environmental and nutritional factors might play a role in triggering medullary aplasia.

New Section

This part delves into the concept of plasticity, emphasizing possible expansion when needed and the corresponding hematopoiesis restriction based on maturation evolution and age.

Concept of Plasticity in Hematopoiesis

• Plasticity refers to the potential for mobility and expansion as required.

• Hematopoiesis is restricted based on maturation evolution and age.

New Section

Here, the discussion centers around stem cells' ability to generate a vast number of mature cells through proliferation tied to cellular kinetics.

Stem Cell Proliferation and Differentiation

• A single stem cell can produce a large number of mature cells through proliferation.

• Proliferation is linked to cellular kinetics based on cellular needs and lifespans.

New Section

This segment explores how inhibiting differentiation can lead to cell accumulation at the stem cell stage, potentially causing neoplasms like leukemia.

Inhibition of Differentiation Leading to Neoplasms

• Inhibiting differentiation can result in cell accumulation at the stem cell stage.

• This mechanism can give rise to neoplasms such as leukemia.

New Section

The conversation focuses on blocking self-renewal capacity leading cells towards continuous proliferation, differentiation, and eventual appearance of medullary aplasia.

Impact of Blocking Self-Renewal Capacity

• Blocking self-renewal capacity leads cells towards continuous proliferation.

Aplasia Medular: Causes and Genetic Factors

The discussion delves into the possible causes of aplasia medular, focusing on defects in the microenvironment rather than stem cells. It explores experimental observations related to the inability to correct the bone marrow microenvironment through stem cell transplantation.

Possible Causes of Aplasia Medular

• Stem cells from a normal mouse can restore normal hematopoiesis in a lethally irradiated mouse with damaged bone marrow microenvironment.

• Differentiated situations include exclusive precursor deficiency in the bone marrow, known as congenital hypoplastic anemia or Diamond anemia.

• Distinguishing between congenital hypoplastic anemia and transient erythroblastopenia in childhood is crucial for accurate diagnosis.

Genetic Determinants of Aplastic Anemias

This segment focuses on hereditary and acquired forms of aplastic anemias, highlighting genetic factors contributing to pancitopenia and erythroblastopenias.

Hereditary vs. Acquired Aplastic Anemias

• Hereditary forms are less common but can lead to pancitopenia or specific erythroblastopenias.

• Identification of genes responsible for congenital erythropoietic disorders has shed light on rare pathologies linked not only to anemia but also other diseases.

Hereditary Forms of Red Cell Series Aplasias

Exploring specific hereditary red cell series aplasias such as hereditary elliptocytosis (HE), emphasizing mutations affecting red blood cell membrane proteins.

Hereditary Elliptocytosis (HE)

• HE, characterized by hemolytic anemia under acidic conditions due to mutations impacting red blood cell membrane proteins assembly.

• Various mutations causing assembly failure result in compact Band 3 in patients compared to controls, indicating truncated glycans presence.

Molecular Insights into Aplastic Anemias

Delving into molecular aspects of aplastic anemias beyond mere anemia, discussing ten significant diseases associated with type 2 dyserythropoiesis.

Molecular Mechanisms and Disease Associations

• Genes linked to Fanconi's anemia influence cellular stress response, proliferation, differentiation capacity, potentially leading to leukemia development.

Detailed Analysis of Immune System Response

In this section, the speaker discusses the immune system response and its implications in autoimmune conditions.

The Importance of Immune System Hypothesis

• The immune system's role in autoimmunity is crucial, with T lymphocyte competition being a significant mechanism supported by clinical evidence.

Immunological Impact on Stems

• The immune system's intended protection can inadvertently target stems not only through direct cytotoxicity but also via inflammatory cytokines affecting hematopoietic stems.

Clinical Treatment Considerations

• Interleukins or cytokines from patients' bone marrow mononuclear cells inhibit erythropoietic or hematopoietic blast proliferation, influencing treatment choices like immunosuppression and bone marrow transplants.

Understanding Placia Development Stages

This segment delves into the distinct stages of placia development and associated clinical considerations.

Three Differentiated Placia Development Phases

• Placia development involves initial damage to medullary stems, followed by a later abrupt decline in peripheral cellular mass circulation. Subsequently, rescue mechanisms may attempt to restore significant hypoplastic medulla.

Long-Term Implications and Potential Relapse

• Over time, patients may experience differentiated cell clone relapses originating from previously attacked medullary cells due to immune evasion mechanisms. This could lead to conditions like paroxysmal nocturnal hemoglobinuria or myelodysplastic syndrome.

Mechanisms of Cell Attack and Survival

Exploring the mechanisms behind cell attack, survival strategies, and their implications on disease progression.

Cell Apoptosis Induction Mechanisms

• Cytokines trigger cell apoptosis through T cell activation and expansion, leading to CD59 receptor targeting for cellular death signaling. Fas ligand plays a critical role in inducing apoptosis for cell survival against attacks.

Genetic Mutations and Cellular Protection

• Mutations in genes like CD55 and CD59 prevent protein anchoring structures' formation, protecting stem cells from apoptotic signals while leaving mature peripheral cells vulnerable to complement attack.

Understanding Paroxysmal Nocturnal Hemoglobinuria (PNH)

Delving into the characteristics of PNH, including its pathophysiology and impact on cellular integrity.

PNH Pathogenesis Insights

• PNH aims at preserving medullary integrity by sacrificing red blood cells through hemolysis. This process highlights the balance between maintaining stem cell proliferation versus peripheral hemolysis risks.

Clinical Implications and Cellular Dynamics